Symmetric increased skeletal muscular uptake of F-18 fluoro-deoxyglucose: A clue for the diagnosis of Graves’ disease

F-18 fluoro-deoxyglucose (FDG) uptake in the thyroid and thymus is well reported in patients with Graves’ disease. Incidental skeletal muscle uptake has also been reported in other non-musculoskeletal (benign and malignant) pathologies. We report a patient of Graves’ disease showing symmetrical skel...

Descripción completa

Detalles Bibliográficos
Autores principales: Santhosh, Sampath, Mittal, Bhagwant Rai, Kashyap, Raghava, Bhattacharya, Anish, Singh, Baljinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543583/
https://www.ncbi.nlm.nih.gov/pubmed/23326069
http://dx.doi.org/10.4103/0972-3919.104000
Descripción
Sumario:F-18 fluoro-deoxyglucose (FDG) uptake in the thyroid and thymus is well reported in patients with Graves’ disease. Incidental skeletal muscle uptake has also been reported in other non-musculoskeletal (benign and malignant) pathologies. We report a patient of Graves’ disease showing symmetrical skeletal muscle uptake but no thyroidal or thymus uptake of FDG.

Ejemplares similares